OPT News: Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ - 28th Apr 2023, 7:30pm

annb0t

Top 20
Opthea Limited

MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that management will participate in the one-on-one meeting portion of the H.C. Wainwright BioConnect Conference being held on May 2, 2023. The Conference is produced in partnership with NASDAQ and will take place at the exchange’s world h...

>>> Read more: Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
 
Top Bottom